GO
Loading...

Elan Corporation PLC

More

  • In total, SAC Capital has agreed to pay $1.8 billion to resolve criminal and civil probes into insider trading. SAC Capital also agreed to be placed on probation for five years, and employ a compliance consultant, former federal prosecutor Bart Schwartz.

  • In total, SAC Capital has agreed to pay $1.8 billion to resolve criminal and civil probes into insider trading. SAC Capital also agreed to be placed on probation for five years, and employ a compliance consultant, former federal prosecutor Bart Schwartz. The sentencing marks the end of an era for SAC Capital, which by last year had managed $15 billion of assets.

  • NEW YORK, Feb 28- Former SAC Capital Advisors LP portfolio manager Mathew Martoma asked a U.S. judge to throw out his insider trading conviction, saying federal prosecutors did not prove he committed a crime and that improper evidence and jury bias tainted the verdict. The request submitted late Thursday night in the U.S. District Court in Manhattan was expected.

  • NEW YORK, Feb 6- Mathew Martoma, a former portfolio manager at billionaire Steven A. Cohen's SAC Capital Advisors hedge fund, was found guilty on Thursday of engaging in what prosecutors called the most lucrative insider trading scheme in U.S. history.

  • NEW YORK, Feb 4- A jury began deliberating on Tuesday on whether to convict Mathew Martoma of insider trading stemming from trades made while working at Steven A. Cohen's SAC Capital Advisors hedge fund, in what prosecutors called the most lucrative such scheme in U.S. history.

  • Insider trading case of SAC's Martoma goes to jury Tuesday, 4 Feb 2014 | 12:20 PM ET

    NEW YORK, Feb 4- A jury began deliberating on Tuesday on whether to convict Mathew Martoma of insider trading stemming from trades made while working at Steven A. Cohen's SAC Capital Advisors hedge fund, in what prosecutors called the most lucrative such scheme in U.S. history.

  • Martoma, Strassberg added, was the victim of a "rush to judgment" by investigators whose true target was Steven A. Cohen, the founder of SAC Capital, who has not been criminally charged.

  • U.S. asks jurors to convict SAC's Martoma Monday, 3 Feb 2014 | 2:18 PM ET

    NEW YORK, Feb 3- Mathew Martoma sought out a "canary in the coal mine" to give him inside information on drug companies, a federal prosecutor said on Monday, urging jurors to convict the former SAC Capital Advisors portfolio manager of insider trading.

  • Martoma, 39, is accused of using inside information about a drug trial to trade in the stock of Elan Corp Plc and Wyeth that helped SAC Capital make profits and avoid losses of $276 million.

  • NEW YORK, Jan 27- Steven A. Cohen's ex-wife, who accused the billionaire hedge fund founder of hiding $5.5 million during their 1990 divorce, can pursue fraud claims against him but cannot go after him for racketeering, a federal judge ruled on Monday.

  • NEW YORK, Jan 23- An FBI agent who was investigating SAC Capital Advisors portfolio manager Mathew Martoma in 2011 said the trader was just a "grain of sand" in a wider probe targeting the hedge fund's founder, Steven A. Cohen, a government witness said on Thursday.

  • NEW YORK, Jan 23- A doctor who says he leaked details of a clinical drug trial to SAC Capital Advisors portfolio manager Mathew Martoma also discussed the drug under development with other investors, according to documents displayed in court on Thursday.

  • NEW YORK, Jan 17- A former University of Michigan neurology professor took the stand on Friday as the government's star witness in the insider trading trial of Mathew Martoma, saying he divulged confidential information about a drug trial to the former SAC Capital Advisors trader.

  • NEW YORK, Jan 17- A former University of Michigan neurology professor took the stand on Friday as the government's star witness in the insider trading trial of Mathew Martoma, saying he divulged confidential information about a drug trial to the former SAC Capital Advisors trader.

  • Joel Ross, a New Jersey doctor involved in the clinical trial for an Alzheimer's drug, told jurors in federal court in New York that he met with Martoma in July 2008 just after he and other doctors involved in the study were told the results of the trial.

  • Joel Ross, a New Jersey doctor involved in the clinical trial for an Alzheimer's drug, told jurors in federal court in New York that he met with Martoma in July 2008 just after he and other doctors involved in the study were told the results of the trial.

  • Martoma trial: Ex-SAC trader was expelled by Harvard Friday, 10 Jan 2014 | 7:55 AM ET
    Mathew Martoma

    Former SAC trader Mathew Martoma forged a Harvard transcript, falsified an email and created a dummy forensic computing company to try to cover his tracks, according to a court document.

  • NEW YORK, Jan 8- Mathew Martoma, a former SAC Capital Advisors portfolio manager on trial on charges of insider trading, cannot introduce excerpts from a deposition of his former boss, billionaire Steven A. Cohen, a federal judge ruled on Wednesday.

  • UPDATE 1-Trial to focus on trades by SAC's Cohen Monday, 6 Jan 2014 | 12:44 PM ET

    NEW YORK, Jan 6- A trial starting this week over what U.S. prosecutors call the most lucrative insider trading scheme ever will likely delve into the trading activity of Steven A. Cohen, founder of the SAC Capital Advisors hedge fund.

  • PREVIEW-Trial to home in on trades by SAC's Cohen Monday, 6 Jan 2014 | 1:00 AM ET

    NEW YORK, Jan 6- A trial starting this week over what prosecutors call the most lucrative insider trading scheme ever will likely delve into the trading activity of Steven A. Cohen, the founder of the SAC Capital Advisors hedge fund.

Most Popular Video

Monday, 21 Apr 2014 | 12:02 AM ET

Simon Grose-hodge, Head of Investment Advisory, South Asia at LGT Bank Singapore, remains overweight on developed markets as the U.S. and Europe are showing signs of recovery.

Sunday, 20 Apr 2014 | 9:42 PM ET

Caroline Russell, CEO of Boh Plantations, speaks to CNBC's Julia Wood about the company's focus on maintaining dominance in its home market of Malaysia.

Sunday, 20 Apr 2014 | 8:47 PM ET

As the Beijing Auto Show kicks off on Monday, Martin Winterkorn, Chairman and CEO at Volkswagen, says plug-in hybrids will dominate its lineup in China for alternative energy cars.